|

Mid-day market update: Dow falls 100 points; Can-Fite BioPharma (CANF Stock) shares jump

Midway through trading Tuesday, the Dow traded down 0.33% to 32,844.83 while the NASDAQ rose 0.96% to 13,588.85. The S&P also rose, gaining 0.11% to 3,973.31.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 29,496,140 cases with around 535,650 deaths. Brazil reported over 11,519,600 COVID-19 cases with 279,280 deaths, while India confirmed a total of at least 11,409,830 cases and 158,850 deaths. In total, there were at least 120,338,070 cases of COVID-19 worldwide with more than 2,662,990 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Communication services shares rose 1.4% on Monday. Meanwhile, top gainers in the sector included Lizhi Inc. LIZI 28.18%, up 31%, and Zedge, Inc. ZDGE 17.06%, up 23%.

In trading on Monday, energy shares fell 2.6%.

Top Headline

Jabil Inc. JBL 2.86% reported better-than-expected results for its second quarter and raised FY21 guidance.

Jabil posted quarterly earnings of $1.27 per share, beating analysts’ estimates of $0.95 per share. The company’s quarterly sales came in at $6.83 billion, exceeding expectations of $6.57 billion.

Equities Trading UP

SunLink Health Systems, Inc. SSY 203.65% shares shot up 190% to $5.59 as the company reported $2 million expansion, capital and operating improvements at Trace Regional Hospital.

Shares of Savara Inc. SVRA 37.01% got a boost, shooting 31% to $2.31 after the company's CFO disclosed an open market purchase of 13,793 shares at $1.45 per share. Piper Sandler initiated coverage on Savara with an Overweight rating and announced a price target of $7.

Can-Fite BioPharma Ltd. CANF 55.44% shares were also up, gaining 49% to $3.0390 after the company announced it has signed a $42.7 million out-licensing deal with Ewopharma. Can-Fite will receive $2.25 million upfront and an additional $40.45 million upon achievement of milestones.

Check out these big movers of the day

Equities Trading DOWN

CleanSpark, Inc. CLSK 22.39% shares tumbled 22% to $22.86 after the company reported pricing of $200 million underwritten public offering.

Shares of Kaspien Holdings Inc. KSPN 27.09% were down 28% to $30.45 after the company reported a bought deal offering of 416,600 shares of common stock at $32.50 per share.

Solid Biosciences Inc. SLDB 29.97% was down, falling 30% to $6.67 after the company reported interim functional, biomarker data, and patient-reported outcome measures from its ongoing IGNITE Phase 1/2 trial of its lead gene therapy candidate, SGT-001 in Duchenne muscular dystrophy (DMD)..

Commodities

In commodity news, oil traded down 1.6% to $64.37, while gold traded down 0.1% to $1,727.90.

Silver traded down 1.2% Tuesday to $25.985 while copper fell 1.5% to $25.985.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 gained 0.88%, the Spanish Ibex Index rose 0.29% and the German DAX 30 gained 0.89%. Meanwhile, the French CAC 40 rose 0.42%, London’s FTSE 100 rose 0.69% and Italy’s FTSE MIB rose 0.57%.

The ZEW Indicator of Economic Sentiment for the Eurozone increased 4.4 points to 74 in March, while the German ZEW Indicator of Economic Sentiment increased by 5.4 points to 76.6 in March. French consumer price inflation rate was revised higher to 0.6% year-over-year in February.

Economics

The Federal Open Market Committee will start its two-day policy meeting today.

Retail sales dropped 3% in February versus a revised 7.6% surge in January.

Import prices rose 1.3% in February, while prices for US exports rose 1.6%.

Industrial production declined 2.2% in February, following a revised 1.1% rise in the previous month.

US business inventories rose 0.3% for January.

The NAHB housing market index dropped 2 points to 82 in March.

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD moves sideways below 1.1800 on Christmas Eve

EUR/USD struggles to find direction and trades in a narrow channel below 1.1800 after posting gains for two consecutive days. Bond and stock markets in the US will open at the usual time and close early on Christmas Eve, allowing the trading action to remain subdued. 

GBP/USD keeps range around 1.3500 amid quiet markets

GBP/USD keeps its range trade intact at around 1.3500 on Wednesday. The Pound Sterling holds the upper hand over the US Dollar amid pre-Christmas light trading as traders move to the sidelines heading into the holiday season. 

Gold retreats from record highs, trades below $4,500

Gold retreats after setting a new record-high above $4,520 earlier in the day and trades in a tight range below $4,500 as trading volumes thin out ahead of the Christmas break. The US Dollar selling bias remains unabated on the back of dovish Fed expectations, which continues to act as a tailwind for the bullion amid persistent geopolitical risks.

Bitcoin slips below $87,000 as ETF outflows intensify, whale participation declines

Bitcoin price continues to trade around $86,770 on Wednesday, after failing to break above the $90,000 resistance. US-listed spot ETFs record an outflow of $188.64 million on Tuesday, marking the fourth consecutive day of withdrawals.

Economic outlook 2026-2027 in advanced countries: Solidity test

After a year marked by global economic resilience and ending on a note of optimism, 2026 looks promising and could be a year of solid economic performance. In our baseline scenario, we expect most of the supportive factors at work in 2025 to continue to play a role in 2026.

Avalanche struggles near $12 as Grayscale files updated form for ETF

Avalanche trades close to $12 by press time on Wednesday, extending the nearly 2% drop from the previous day. Grayscale filed an updated form to convert its Avalanche-focused Trust into an ETF with the US Securities and Exchange Commission.